Thomas Jansen

3.4k total citations
46 papers, 2.5k citations indexed

About

Thomas Jansen is a scholar working on Physiology, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Thomas Jansen has authored 46 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Physiology, 14 papers in Molecular Biology and 11 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Thomas Jansen's work include Nitric Oxide and Endothelin Effects (15 papers), Eicosanoids and Hypertension Pharmacology (7 papers) and Adipose Tissue and Metabolism (4 papers). Thomas Jansen is often cited by papers focused on Nitric Oxide and Endothelin Effects (15 papers), Eicosanoids and Hypertension Pharmacology (7 papers) and Adipose Tissue and Metabolism (4 papers). Thomas Jansen collaborates with scholars based in Germany, United States and France. Thomas Jansen's co-authors include Andreas Daiber, Thomas Münzel, Philip Wenzel, Eberhard Schulz, Matthias Oelze, Swenja Kröller‐Schön, Elizabeth Ramos‐Lopez, Klaus Badenhoop, Klaus Olek and Matthew E. Hurles and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Immunity.

In The Last Decade

Thomas Jansen

46 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas Jansen Germany	25	794	543	389	370	364	46	2.5k
Keisuke Fukuo Japan	29	1000 1.3×	833 1.5×	454 1.2×	372 1.0×	199 0.5×	181	3.1k
Ken‐ichi Aihara Japan	29	813 1.0×	325 0.6×	561 1.4×	682 1.8×	347 1.0×	117	2.8k
Chiara Bolego Italy	31	810 1.0×	368 0.7×	307 0.8×	530 1.4×	497 1.4×	83	2.9k
Takanobu Taniguchi Japan	33	1.5k 1.9×	473 0.9×	253 0.7×	373 1.0×	436 1.2×	105	3.1k
Matthias Kapturczak United States	18	1.2k 1.5×	651 1.2×	385 1.0×	101 0.3×	419 1.2×	27	2.3k
Radha Ananthakrishnan United States	30	1.1k 1.3×	430 0.8×	390 1.0×	434 1.2×	197 0.5×	114	2.8k
Hiroki Fujita Japan	30	1.2k 1.6×	624 1.1×	262 0.7×	852 2.3×	328 0.9×	103	3.7k
Marie L. Foegh United States	30	585 0.7×	369 0.7×	513 1.3×	542 1.5×	372 1.0×	124	3.0k
Ferruh Artunç Germany	32	1.2k 1.6×	677 1.2×	347 0.9×	648 1.8×	165 0.5×	134	3.3k
Roy L. Sutliff United States	40	2.0k 2.5×	789 1.5×	711 1.8×	309 0.8×	249 0.7×	104	4.2k

Countries citing papers authored by Thomas Jansen

Since Specialization

Citations

This map shows the geographic impact of Thomas Jansen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Jansen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Jansen more than expected).

Fields of papers citing papers by Thomas Jansen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Jansen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Jansen. The network helps show where Thomas Jansen may publish in the future.

Co-authorship network of co-authors of Thomas Jansen

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Jansen. A scholar is included among the top collaborators of Thomas Jansen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Jansen. Thomas Jansen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jansen, Thomas, Miroslava Kvandová, Sanela Kalinovic, et al.. (2021). Lack of Endothelial α1AMPK Reverses the Vascular Protective Effects of Exercise by Causing eNOS Uncoupling. Antioxidants. 10(12). 1974–1974. 5 indexed citations

Göbel, Sebastian, Thomas Jansen, Susanne Karbach, et al.. (2020). Safety of Transradial and Transfemoral Left Ventricular Compared with Transfemoral Right Ventricular Endomyocardial Biopsy. ESC Heart Failure. 7(6). 4015–4023. 8 indexed citations

Steven, Sebastian, Matthias Oelze, Michael Hausding, et al.. (2018). The Endothelin Receptor Antagonist Macitentan Improves Isosorbide‐5‐Mononitrate (ISMN) and Isosorbide Dinitrate (ISDN) Induced Endothelial Dysfunction, Oxidative Stress, and Vascular Inflammation. Oxidative Medicine and Cellular Longevity. 2018(1). 7845629–7845629. 12 indexed citations

Oelze, Matthias, Philipp Welschof, Maike Knorr, et al.. (2017). Basic in vitro Characterization of the Vasodilatory Potential of 2-Aminoethyl Nitrate Fixed-Dose Combinations with Cilostazol, Metoprolol and Valsartan. Pharmacology. 101(1-2). 54–63. 1 indexed citations

Gori, Tommaso, Thomas Jansen, Melissa Weissner, et al.. (2015). Coronary evaginations and peri-scaffold aneurysms following implantation of bioresorbable scaffolds: incidence, outcome, and optical coherence tomography analysis of possible mechanisms. European Heart Journal. 37(26). 2040–2049. 40 indexed citations

Jabs, Alexander, Matthias Oelze, Yuliya Mikhed, et al.. (2015). Effect of soluble guanylyl cyclase activator and stimulator therapy on nitroglycerin-induced nitrate tolerance in rats. Vascular Pharmacology. 71. 181–191. 28 indexed citations

Oelze, Matthias, Swenja Kröller‐Schön, Philipp Welschof, et al.. (2014). The Sodium-Glucose Co-Transporter 2 Inhibitor Empagliflozin Improves Diabetes-Induced Vascular Dysfunction in the Streptozotocin Diabetes Rat Model by Interfering with Oxidative Stress and Glucotoxicity. PLoS ONE. 9(11). e112394–e112394. 260 indexed citations

Knorr, Maike, Michael Hausding, Kerstin Jurk, et al.. (2014). In vitro and in vivo Characterization of a New Organic Nitrate Hybrid Drug Covalently Bound to Pioglitazone. Pharmacology. 93(5-6). 203–215. 3 indexed citations

Karbach, Susanne, Thomas Jansen, Sven Horke, et al.. (2012). Hyperglycemia and oxidative stress in cultured endothelial cells – a comparison of primary endothelial cells with an immortalized endothelial cell line. Journal of Diabetes and its Complications. 26(3). 155–162. 39 indexed citations

10.

Maas, Coen, Bernd Lecher, Thomas Jansen, et al.. (2011). Mast Cells Increase Vascular Permeability by Heparin-Initiated Bradykinin Formation In Vivo. Immunity. 34(2). 258–268. 200 indexed citations

11.

Jansen, Thomas, Marcus Hortmann, Matthias Oelze, et al.. (2010). Conversion of biliverdin to bilirubin by biliverdin reductase contributes to endothelial cell protection by heme oxygenase-1—evidence for direct and indirect antioxidant actions of bilirubin. Journal of Molecular and Cellular Cardiology. 49(2). 186–195. 145 indexed citations

12.

Daiber, Andreas, Matthias Oelze, Philip Wenzel, et al.. (2009). Nitrate tolerance as a model of vascular dysfunction: Roles for mitochondrial aldehyde dehydrogenase and mitochondrial oxidative stress. Pharmacological Reports. 61(1). 33–48. 52 indexed citations

13.

Daiber, Andreas, Philip Wenzel, Matthias Oelze, et al.. (2008). Mitochondrial aldehyde dehydrogenase (ALDH-2)—Maker of and marker for nitrate tolerance in response to nitroglycerin treatment. Chemico-Biological Interactions. 178(1-3). 40–47. 34 indexed citations

14.

Ramos‐Lopez, Elizabeth, Patrick T. Bruck, Thomas Jansen, Jürgen Herwig, & Klaus Badenhoop. (2007). CYP2R1 (vitamin D 25‐hydroxylase) gene is associated with susceptibility to type 1 diabetes and vitamin D levels in Germans. Diabetes/Metabolism Research and Reviews. 23(8). 631–636. 138 indexed citations

15.

Cybulla, Markus, Walter K.K. Ho, H. Neumann, et al.. (2007). Morbus Fabry: Demografische Übersicht seit Einführung der Enzymersatztherapie. DMW - Deutsche Medizinische Wochenschrift. 132(28/29). 1505–1509. 8 indexed citations

16.

Ramos‐Lopez, Elizabeth, Patrick T. Bruck, Thomas Jansen, et al.. (2007). CYP2R1-, CYP27B1- and CYP24-mRNA expression in German type 1 diabetes patients. The Journal of Steroid Biochemistry and Molecular Biology. 103(3-5). 807–810. 30 indexed citations

17.

Ramos‐Lopez, Elizabeth, Thomas Jansen, Vytautas Ivaškevičius, et al.. (2006). Protection From Type 1 Diabetes by Vitamin D Receptor Haplotypes. Annals of the New York Academy of Sciences. 1079(1). 327–334. 58 indexed citations

18.

Jansen, Thomas, et al.. (2004). The Fabry Outcome Survey is a useful tool to document the natural history of Fabry disease. UCL Discovery (University College London). 1 indexed citations

19.

Jansen, Thomas & Gerd Plewig. (1998). Clinical and Histological Variants of Rhinophyma, Including Nonsurgical Treatment Modalities. Facial Plastic Surgery. 14(4). 241–253. 50 indexed citations

20.

Stimpel, Michael, et al.. (1996). Moexipril Versus Captopril in Patients with Mild to Moderate Hypertension. Journal of Cardiovascular Pharmacology. 28(6). 769–773. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact